Amylyx Pharmaceuticals, Inc.

Q4 2023 13F Holders

Symbol
AMLX
CUSIP
03237H101
Type
Equity
Class
COM
Num filings
213
Total reported value, excl. options
$958 M
Manager Report Date Value ($000) Shares Option Type